Thanks Disco - I missed that in the Chairman's preso. Explains it!
So, based on that and the notes in the trial page, it looks like the Liverpool Hospital data set being collected in parallel with the 5-site validation trial, is for the purpose of producing a V2 algorithm - with both a 'higher performance capability' for the 'stroke-no stroke' function of the existing V1 algorithm and, potentially, 'additional functionality' with new brain issue targets.
Thanks Disco - I missed that in the Chairman's preso. Explains...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.75 |
Change
0.010(0.57%) |
Mkt cap ! $149.6M | |||
| Open | High | Low | Value | Volume |
| $1.76 | $1.77 | $1.75 | $26.27K | 15.00K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2701 | $1.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.77 | 2782 | 1 |
View Market Depth
| Last trade - 16.10pm 23/06/2025 (20 minute delay) ? |
| EMV (ASX) Chart |